Koninklijke Philips (NYSE:PHG) Shares Acquired by Ritholtz Wealth Management

Ritholtz Wealth Management boosted its position in Koninklijke Philips (NYSE:PHG) by 20.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,068 shares of the technology company’s stock after buying an additional 1,562 shares during the period. Ritholtz Wealth Management’s holdings in Koninklijke Philips were worth $517,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the stock. Alliancebernstein L.P. grew its position in Koninklijke Philips by 20.3% in the 1st quarter. Alliancebernstein L.P. now owns 2,276,703 shares of the technology company’s stock valued at $129,840,000 after buying an additional 383,794 shares during the last quarter. Wells Fargo & Company MN grew its position in Koninklijke Philips by 6.8% in the 4th quarter. Wells Fargo & Company MN now owns 1,452,179 shares of the technology company’s stock valued at $78,665,000 after buying an additional 92,584 shares during the last quarter. TPG Group Holdings SBS Advisors Inc. grew its position in Koninklijke Philips by 2.8% in the 4th quarter. TPG Group Holdings SBS Advisors Inc. now owns 1,370,210 shares of the technology company’s stock valued at $74,224,000 after buying an additional 37,300 shares during the last quarter. Northern Trust Corp grew its position in Koninklijke Philips by 8.1% in the 4th quarter. Northern Trust Corp now owns 1,026,540 shares of the technology company’s stock valued at $55,608,000 after buying an additional 76,510 shares during the last quarter. Finally, Natixis Advisors L.P. grew its position in Koninklijke Philips by 2.0% in the 1st quarter. Natixis Advisors L.P. now owns 710,588 shares of the technology company’s stock valued at $40,524,000 after buying an additional 14,151 shares during the last quarter. Hedge funds and other institutional investors own 8.36% of the company’s stock.

A number of research firms recently weighed in on PHG. Zacks Investment Research lowered shares of Koninklijke Philips from a “buy” rating to a “hold” rating and set a $56.00 price objective on the stock. in a research report on Tuesday, March 9th. Berenberg Bank restated a “buy” rating on shares of Koninklijke Philips in a research report on Thursday, April 29th. Barclays restated an “overweight” rating on shares of Koninklijke Philips in a research report on Tuesday, March 23rd. Credit Suisse Group restated a “neutral” rating on shares of Koninklijke Philips in a research report on Wednesday, April 28th. Finally, JPMorgan Chase & Co. upgraded shares of Koninklijke Philips from a “neutral” rating to an “overweight” rating in a research report on Thursday, March 18th. One analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the stock. Koninklijke Philips has a consensus rating of “Buy” and an average target price of $56.00.

NYSE:PHG opened at $56.49 on Friday. The firm has a market cap of $51.13 billion, a P/E ratio of 37.52, a PEG ratio of 2.08 and a beta of 0.83. The company has a quick ratio of 1.06, a current ratio of 1.45 and a debt-to-equity ratio of 0.48. Koninklijke Philips has a 52-week low of $43.98 and a 52-week high of $61.23. The stock’s fifty day moving average price is $57.71.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings results on Monday, April 26th. The technology company reported $0.34 earnings per share (EPS) for the quarter. The business had revenue of $4.61 billion during the quarter. Koninklijke Philips had a return on equity of 18.12% and a net margin of 6.20%. On average, equities analysts forecast that Koninklijke Philips will post 2.37 EPS for the current year.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, diagnostic X-ray, and imaging components as well as integrated clinical solutions; integrated interventional systems, including interventional diagnostic and therapeutic devices; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.

Further Reading: What is a CD ladder?

Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips (NYSE:PHG).

Institutional Ownership by Quarter for Koninklijke Philips (NYSE:PHG)

Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.